ICCM News and Press, IceCure Medical Ltd. From 09/18/25

2025-09-18 08:52:09 ET More on IceCure Medical IceCure Medical Ltd (ICCM) Q2 2025 Earnings Call Transcript IceCure Medical GAAP EPS of $0.12, revenue of $1.25M Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for IceCure Medical...

IceCure Granted Notice of Allowance for U.S. Patent for its Next-Generation XSense™ Cryoprobes PR Newswire The invention is designed to improve cryoprobe extraction, further reducing risk of tissue trauma, leading to lower costs and improved patient experience ...

Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals Canada NewsWire Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC , Sept. 16, 2025 /CNW/ -- USA News Group News Commentary – The FDA's ...

2025-09-15 12:31:17 ET IceCure Medical (NASDAQ: ICCM ) has received regulatory clearance from Israel's Ministry of Health for its XSense(TM) Cryoablation System and CryoProbes, the company's next-generation single-probe device for minimally invasive tumor treatment. The approval cov...

IceCure Receives Regulatory Approval in Israel for its Next-Generation XSense™ Cryoablation System for Breast Cancer and Other Indications PR Newswire Approved for a broad range of indications including in gynecology, oncology and general surgery CAESAREA,...

Two New Publications from the Independent THERMAC Trial Featuring IceCure's ProSense® in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense® Cryoablation Achieves Highest Complete Ablation Rate PR Newswire Article published in European Jo...

2025-09-04 17:22:08 ET More on IceCure Medical IceCure Medical GAAP EPS of $0.12, revenue of $1.25M Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for IceCure Medical Financial information for IceCure Medical Read th...

IceCure's ProSense® Substantially Reduces Abdominal Wall Endometriosis Pain with High Procedural Efficacy PR Newswire Independent study reports pain scores declined from a median of 8 on a scale of 0-10 to a median of 0 for patients who had ProSense® cryoablat...

2025-08-28 13:30:26 ET Moleculin Biotech Plunges 33% on Dilutive Financing Moleculin Biotech, Inc. ( MBRX ) sank 32.50%, leading losses in the PRISM Emerging Pharmaceuticals Index , after announcing a $6.0 million capital raise through the immediate exercise of warrants . ...

A look at the top 10 most actives in the United States Erayak Power Solution Group Inc. (RAYA) rose 22.6% to $0.0576 on volume of 241,031,156 shares Top KingWin Ltd (WAI) rose 52.4% to $0.2133 on volume of 155,769,781 shares CaliberCos Inc. (CWD) rose 83.3% to $3.1154 on volume of 95,928,70...